Neutrophils in multiple sclerosis are characterized by a primed phenotype

Journal of Neuroimmunology

Volumn 242, Issue 1-2, 2012, Pages 60-71

  Naegele, Matthias ^a   Tillack, Kati ^a   Reinhardt, Stefanie ^a   Schippling, Sven ^a,b   Martin, Roland ^a,b   Sospedra, Mireia ^a,b  

^a UNIVERSITY MEDICAL CENTER HAMBURG EPPENDORF   (Germany)

^b UNIVERSITY HOSPITAL ZURICH   (Switzerland)

Author keywords

Innate immunity; Multiple sclerosis; Neutrophils; Priming

Indexed keywords

FMLP RECEPTOR; INTERLEUKIN 8 RECEPTOR; LEUKOSIALIN; RECEPTOR; TOLL LIKE RECEPTOR 2; UNCLASSIFIED DRUG;

ANTIGEN EXPRESSION; APOPTOSIS; ARTICLE; CONTROLLED STUDY; DEGRANULATION; EXTRACELLULAR SPACE; HUMAN; INFECTION; LEUKOCYTE ACTIVATION; MAJOR CLINICAL STUDY; MULTIPLE SCLEROSIS; NEUTROPHIL; PHENOTYPE; PRIORITY JOURNAL; PROTEIN EXPRESSION; RESPIRATORY BURST; SERUM;

ADULT; APOPTOSIS; BIOLOGICAL MARKERS; CELL DEGRANULATION; FEMALE; HUMANS; INFLAMMATION MEDIATORS; MALE; MIDDLE AGED; MULTIPLE SCLEROSIS, CHRONIC PROGRESSIVE; MULTIPLE SCLEROSIS, RELAPSING-REMITTING; NEUTROPHIL ACTIVATION; NEUTROPHILS; PHENOTYPE;

EID: 84856804751     PISSN: 01655728     EISSN: 18728421     Source Type: Journal    
DOI: 10.1016/j.jneuroim.2011.11.009     Document Type: Article

References (58)

1. Aoki Y., Miyatake T., Shimizu N., Yoshida M. Medullasin activity in granulocytes of patients with multiple sclerosis. Ann. Neurol. 1984, 15:245-249.
2. Berends C., Dijkhuizen B., de Monchy J.G., Gerritsen J., Kauffman H.F. Induction of low density and up-regulation of CD11b expression of neutrophils and eosinophils by dextran sedimentation and centrifugation. J. Immunol. Methods 1994, 167:183-193.
3. Brandolini L., Bertini R., Bizzarri C., Sergi R., Caselli G., Zhou D., Locati M., Sozzani S. IL-1 beta primes IL-8-activated human neutrophils for elastase release, phospholipase D activity, and calcium flux. J. Leukoc. Biol. 1996, 59:427-434.
4. Brinkmann V., Reichard U., Goosmann C., Fauler B., Uhlemann Y., Weiss D.S., Weinrauch Y., Zychlinsky A. Neutrophil extracellular traps kill bacteria. Science 2004, 303:1532-1535.
5. Carlson T., Kroenke M., Rao P., Lane T.E., Segal B. The Th17-ELR+ CXC chemokine pathway is essential for the development of central nervous system autoimmune disease. J. Exp. Med. 2008, 205:811-823.
6. Chuntharapai A., Lee J., Hebert C.A., Kim K.J. Monoclonal antibodies detect different distribution patterns of IL-8 receptor A and IL-8 receptor B on human peripheral blood leukocytes. J. Immunol. 1994, 153:5682-5688.
7. Colotta F., Re F., Polentarutti N., Sozzani S., Mantovani A. Modulation of granulocyte survival and programmed cell death by cytokines and bacterial products. Blood 1992, 80:2012-2020.
8. Condliffe A.M., Chilvers E.R., Haslett C., Dransfield I. Priming differentially regulates neutrophil adhesion molecule expression/function. Immunology 1996, 89:105-111.
9. Condliffe A.M., Kitchen E., Chilvers E.R. Neutrophil priming: pathophysiological consequences and underlying mechanisms. Clin. Sci. (Lond) 1998, 94:461-471.
10. Courtney P.A., Crockard A.D., Williamson K., Irvine A.E., Kennedy R.J., Bell A.L. Increased apoptotic peripheral blood neutrophils in systemic lupus erythematosus: relations with disease activity, antibodies to double stranded DNA, and neutropenia. Ann. Rheum. Dis. 1999, 58:309-314.
11. Debruyne J., Philippe J., Dereuck J., Willems A., Leroux-Roels G. Relapse markers in multiple sclerosis: are in vitro cytokine production changes reflected by circulatory T-cell phenotype alterations?. Mult. Scler. 1998, 4:193-197.
12. El Kebir D., Filep J.G. Role of neutrophil apoptosis in the resolution of inflammation. Sci. World J. 2010, 10:1731-1748.
13. Eyles J.L., Roberts A.W., Metcalf D., Wicks I.P. Granulocyte colony-stimulating factor and neutrophils-forgotten mediators of inflammatory disease. Nat. Clin. Pract. Rheumatol. 2006, 2:500-510.
14. Ferretti G., Bacchetti T., DiLudovico F., Viti B., Angeleri V.A., Danni M., Provinciali L. Intracellular oxidative activity and respiratory burst of leukocytes isolated from multiple sclerosis patients. Neurochem. Int. 2006, 48:87-92.
15. Fittschen C., Sandhaus R.A., Worthen G.S., Henson P.M. Bacterial lipopolysaccharide enhances chemoattractant-induced elastase secretion by human neutrophils. J. Leukoc. Biol. 1988, 43:547-556.
16. Fuchs T.A., Abed U., Goosmann C., Hurwitz R., Schulze I., Wahn V., Weinrauch Y., Brinkmann V., Zychlinsky A. Novel cell death program leads to neutrophil extracellular traps. J. Cell Biol. 2007, 176:231-241.
17. Gidday J.M., Gasche Y.G., Copin J.C., Shah A.R., Perez R.S., Shapiro S.D., Chan P.H., Park T.S. Leukocyte-derived matrix metalloproteinase-9 mediates blood-brain barrier breakdown and is proinflammatory after transient focal cerebral ischemia. Am. J. Physiol. Heart Circ. Physiol. 2005, 289:H558-H568.
18. Granieri E., Casetta I., Tola M.R., Ferrante P. Multiple sclerosis: infectious hypothesis. Neurol. Sci. 2001, 22:179-185.
19. Green S.P., Chuntharapai A., Curnutte J.T. Interleukin-8 (IL-8), melanoma growth-stimulatory activity, and neutrophil-activating peptide selectively mediate priming of the neutrophil NADPH oxidase through the type A or type B IL-8 receptor. J. Biol. Chem. 1996, 271:25400-25405.
20. Guarnieri B., Lolli F., Amaducci L. Polymorphonuclear neutral protease activity in multiple sclerosis and other diseases. Ann. Neurol. 1985, 18:620-622.
21. Hampton M.B., Kettle A.J., Winterbourn C.C. Inside the neutrophil phagosome: oxidants, myeloperoxidase, and bacterial killing. Blood 1998, 92:3007-3017.
22. Harper L., Cockwell P., Adu D., Savage C.O. Neutrophil priming and apoptosis in anti-neutrophil cytoplasmic autoantibody-associated vasculitis. Kidney Int. 2001, 59:1729-1738.
23. Hayashi F., Means T.K., Luster A.D. Toll-like receptors stimulate human neutrophil function. Blood 2003, 102:2660-2669.
24. Kessenbrock K., Krumbholz M., Schonermarck U., Back W., Gross W.L., Werb Z., Grone H.J., Brinkmann V., Jenne D.E. Netting neutrophils in autoimmune small-vessel vasculitis. Nat. Med. 2009, 15:623-625.
25. Kettritz R., Gaido M.L., Haller H., Luft F.C., Jennette C.J., Falk R.J. Interleukin-8 delays spontaneous and tumor necrosis factor-alpha-mediated apoptosis of human neutrophils. Kidney Int. 1998, 53:84-91.
26. Kuijpers T.W., Tool A.T., van der Schoot C.E., Ginsel L.A., Onderwater J.J., Roos D., Verhoeven A.J. Membrane surface antigen expression on neutrophils: a reappraisal of the use of surface markers for neutrophil activation. Blood 1991, 78:1105-1111.
27. Kumaratilake L.M., Ferrante A., Jaeger T., Rzepczyk C. GM-CSF-induced priming of human neutrophils for enhanced phagocytosis and killing of asexual blood stages of Plasmodium falciparum: synergistic effects of GM-CSF and TNF. Parasite Immunol. 1996, 18:115-123.
28. Kurt-Jones E.A., Mandell L., Whitney C., Padgett A., Gosselin K., Newburger P.E., Finberg R.W. Role of toll-like receptor 2 (TLR2) in neutrophil activation: GM-CSF enhances TLR2 expression and TLR2-mediated interleukin 8 responses in neutrophils. Blood 2002, 100:1860-1868.
29. Lee M.A., Palace J., Stabler G., Ford J., Gearing A., Miller K. Serum gelatinase B, TIMP-1 and TIMP-2 levels in multiple sclerosis. A longitudinal clinical and MRI study. Brain 1999, 122(Pt 2):191-197.
30. Lehrer R.I., Ganz T. Antimicrobial peptides in mammalian and insect host defence. Curr. Opin. Immunol. 1999, 11:23-27.
31. Lock C., Hermans G., Pedotti R., Brendolan A., Schadt E., Garren H., Langer-Gould A., Strober S., Cannella B., Allard J., Klonowski P., Austin A., Lad N., Kaminski N., Galli S.J., Oksenberg J.R., Raine C.S., Heller R., Steinman L. Gene-microarray analysis of multiple sclerosis lesions yields new targets validated in autoimmune encephalomyelitis. Nat. Med. 2002, 8:500-508.
32. Logters T., Margraf S., Altrichter J., Cinatl J., Mitzner S., Windolf J., Scholz M. The clinical value of neutrophil extracellular traps. Med. Microbiol. Immunol. 2009, 198:211-219.
33. Lucchinetti C.F., Mandler R.N., McGavern D., Bruck W., Gleich G., Ransohoff R.M., Trebst C., Weinshenker B., Wingerchuk D., Parisi J.E., Lassmann H. A role for humoral mechanisms in the pathogenesis of Devic's neuromyelitis optica. Brain 2002, 125:1450-1461.
34. Lund B.T., Ashikian N., Ta H.Q., Chakryan Y., Manoukian K., Groshen S., Gilmore W., Cheema G.S., Stohl W., Burnett M.E., Ko D., Kachuck N.J., Weiner L.P. Increased CXCL8 (IL-8) expression in Multiple Sclerosis. J. Neuroimmunol. 2004, 155:161-171.
35. McColl S.R., Staykova M.A., Wozniak A., Fordham S., Bruce J., Willenborg D.O. Treatment with anti-granulocyte antibodies inhibits the effector phase of experimental autoimmune encephalomyelitis. J. Immunol. 1998, 161:6421-6426.
36. McKay F.C., Swain L.I., Schibeci S.D., Rubio J.P., Kilpatrick T.J., Heard R.N., Stewart G.J., Booth D.R. Haplotypes of the interleukin 7 receptor alpha gene are correlated with altered expression in whole blood cells in multiple sclerosis. Genes Immun. 2008, 9:1-6.
37. Mossberg N., Movitz C., Hellstrand K., Bergstrom T., Nilsson S., Andersen O. Oxygen radical production in leukocytes and disease severity in multiple sclerosis. J. Neuroimmunol. 2009, 213:131-134.
38. Naess A., Nyland H., Glette J., Larsen J.P., Rygh T., Solberg C.O. Granulocyte function in patients with multiple sclerosis. Acta Pathol. Microbiol. Immunol. Scand. C 1986, 94:89-90.
39. Nathan C. Neutrophils and immunity: challenges and opportunities. Nat. Rev. Immunol. 2006, 6:173-182.
40. Olsson T., Zhi W.W., Hojeberg B., Kostulas V., Jiang Y.P., Anderson G., Ekre H.P., Link H. Autoreactive T lymphocytes in multiple sclerosis determined by antigen-induced secretion of interferon-gamma. J. Clin. Invest. 1990, 86:981-985.
41. Pelletier M., Maggi L., Micheletti A., Lazzeri E., Tamassia N., Costantini C., Cosmi L., Lunardi C., Annunziato F., Romagnani S., Cassatella M.A. Evidence for a cross-talk between human neutrophils and Th17 cells. Blood 2010, 115:335-343.
42. Podikoglou D.G., Lianou P.E., Tsakanikas C.D., Papavassiliou J.T. Polymorphonuclear leukocyte functions and multiple sclerosis. Neurology 1994, 44:129-132.
43. Polman C.H., Reingold S.C., Edan G., Filippi M., Hartung H.P., Kappos L., Lublin F.D., Metz L.M., McFarland H.F., O'Connor P.W., Sandberg-Wollheim M., Thompson A.J., Weinshenker B.G., Wolinsky J.S. Diagnostic criteria for multiple sclerosis: 2005 revisions to the "McDonald Criteria". Ann. Neurol. 2005, 58:840-846.
44. Segal A.W. How neutrophils kill microbes. Annu. Rev. Immunol. 2005, 23:197-223.
45. Sospedra M., Martin R. Immunology of multiple sclerosis. Annu. Rev. Immunol. 2005, 23:683-747.
46. Stark M.A., Huo Y., Burcin T.L., Morris M.A., Olson T.S., Ley K. Phagocytosis of apoptotic neutrophils regulates granulopoiesis via IL-23 and IL-17. Immunity 2005, 22:285-294.
47. Swain S.D., Rohn T.T., Quinn M.T. Neutrophil priming in host defense: role of oxidants as priming agents. Antioxid. Redox Signal. 2002, 4:69-83.
48. Tani K., Murphy W.J., Chertov O., Oppenheim J.J., Wang J.M. The neutrophil granule protein cathepsin G activates murine T lymphocytes and upregulates antigen-specific IG production in mice. Biochem. Biophys. Res. Commun. 2001, 282:971-976.
49. Toba K., Koike T., Shibata A., Hashimoto S., Takahashi M., Masuko M., Azegami T., Takahashi H., Aizawa Y. Novel technique for the direct flow cytofluorometric analysis of human basophils in unseparated blood and bone marrow, and the characterization of phenotype and peroxidase of human basophils. Cytometry 1999, 35:249-259.
50. Tzartos J.S., Friese M.A., Craner M.J., Palace J., Newcombe J., Esiri M.M., Fugger L. Interleukin-17 production in central nervous system-infiltrating T cells and glial cells is associated with active disease in multiple sclerosis. Am. J. Pathol. 2008, 172:146-155.
51. Vischer T.L., Bretz U., Baggiolini M. In vitro stimulation of lymphocytes by neutral proteinases from human polymorphonuclear leukocyte granules. J. Exp. Med. 1976, 144:863-872.
52. von Vietinghoff S., Ley K. Homeostatic regulation of blood neutrophil counts. J. Immunol. 2008, 181:5183-5188.
53. Watson F., Robinson J.J., Edwards S.W. Neutrophil function in whole blood and after purification: changes in receptor expression, oxidase activity and responsiveness to cytokines. Biosci. Rep. 1992, 12:123-133.
54. Weiss S.J. Tissue destruction by neutrophils. N. Engl. J. Med. 1989, 320:365-376.
55. Weiss J., Kao L., Victor M., Elsbach P. Oxygen-independent intracellular and oxygen-dependent extracellular killing of Escherichia coli S15 by human polymorphonuclear leukocytes. J. Clin. Invest. 1985, 76:206-212.
56. Wong S.H., Francis N., Chahal H., Raza K., Salmon M., Scheel-Toellner D., Lord J.M. Lactoferrin is a survival factor for neutrophils in rheumatoid synovial fluid. Rheumatology (Oxford) 2009, 48:39-44.
57. Wright H.L., Moots R.J., Bucknall R.C., Edwards S.W. Neutrophil function in inflammation and inflammatory diseases. Rheumatology (Oxford) 2010, 49:1618-1631.
58. Ziaber J., Pasnik J., Baj Z., Pokoca L., Chmielewski H., Tchorzewski H. The immunoregulatory abilities of polymorphonuclear neutrophils in the course of multiple sclerosis. Mediat. Inflamm. 1998, 7:335-338.